People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Other, Pharma, Media & Content, Software / Tech, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neptune Topco Holdings, LLC | — | Other | Series C | $167.8M | $11.1M | 2022 |
| OEC Holding Corp | — | Other | Series B | $28.1M | $467.1M | 2010 |
| Neptune Management Topco Holdings, LLC | — | Other | Series B | $19.7M | $2.0M | 2023 |
| GlyEco, Inc. | — | Other | Series A | $15.4M | $31.8M | 2012 |
| Avisa Pharma Inc. | — | Pharma | Seed | $14.7M | $17.5M | 2013 |
| Midsummer Studios Inc. | — | Media & Content | Series A | $6.8M | $4.9M | 2023 |
| Data Skrive Inc. | — | Software / Tech | Series A | $6.3M | $112.4M | 2021 |
| scanR Inc | — | Other | Series A | $6.2M | $93.7M | 2009 |
| Quaddra Software Inc. | — | Other | Pre-Seed | $580K | $13.4M | 2014 |
| InLight Solutions, Inc. | — | Biotechnology | Pre-Seed | $350K | $19.3M | 2012 |
| Villya Llc | — | Pharmaceuticals | Pre-Seed | $250K | $1.6M | 2023 |
| Xaware Inc | — | Other Technology | Pre-Seed | $156K | $6.6M | 2009 |
William Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bryan Perkins | 2 | 3 |
| Mary Gallagher | 2 | 3 |
| Kevin Layne | 2 | 2 |
| Josh Weisenbeck | 2 | 2 |
| Justin Tucker | 2 | 2 |
| Marc McLeroy | 2 | 2 |
| Robert Recer | 2 | 2 |
| Vance Serchuk | 2 | 2 |
| Bonnie Peat | 2 | 2 |
| Jon Callaghan | 1 | 20 |
| John Glover | 1 | 9 |
| William D. Miller | 1 | 8 |
| David Joseph | 1 | 6 |
| Michael Hand | 1 | 5 |
| John Lorenz | 1 | 4 |
| David S Joseph | 1 | 4 |
| Edward Ekstrom | 1 | 4 |
| Mikal Thomsen | 1 | 4 |
| Stuart Schoenmann | 1 | 4 |
| M. Ries Robinson | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.